Breaking News
Is Big Pharma Selling Postpartum Depression to New Moms?
Make Men Men Again: Low T Is Now a National Defense Problem
Druski: They're Lying To You About Overnight Success!
$6.27 Diesel Just Hit Harvest. The Grocery Aisle Hasn't Felt It Yet.
Top Tech News
Tesla Model 3 killer charges from 10 to 97% in just 9 minutes
World-first unpowered DNA computer sets speed record
I Power 5 Buildings Off-Grid. Here's How
The US government is pushing hard to get a working nuclear fission reactor into space by late 2028
SpaceX Starmind AI in Space Radiator
China Will Dominate Global Nuclear Energy Through 2035, Analyst Says
These Absolutely Wild-Looking EVs Are Saudi Arabia's First Homegrown Cars
BEYOND THE MOON: NASA plans a nuclear-powered fleet to push DEEPER into space
Big Oil Backs Mazama's $135 Million Bet On Superhot Geothermal
Quantum compass takes flight on Northrop's Lumberjack drone 
Flourescent biotechnology for high lighting solid cancer for more complete surgical removal
.... On Target Laboratories LLC is working to advance its revolutionary fluorescent imaging technology that could help surgeons pinpoint and remove more cancerous tissues than has ever been possible while preserving more healthy tissue for patients.
Headquartered at Purdue Research Park of West Lafayette, the company is developing a series of molecules, which, when administered intravenously, show promise in targeting many types of cancer cells, said Dr. Sumith Kularatne, On Target's vice president of research and development.
"In addition to our current U.S. patents, we have 11 more either filed or pending in the U.S.," Kularatne said. "We have another 33 patents pending worldwide. These patents are very important in helping us move our discoveries to the public where they can help people."